In drug-resistant breast cancer MYC is overexpressed, glutamine transporter proteins SLC1A5 and GLS are upregulated, and glutamate metabolism is markedly enhanced to promote proliferation of drug-resistant tumor cells. This evidence concerns the gene SLC1A5 and breast cancer.